Literature DB >> 7800207

Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus.

G Biesenbach1, O Janko, J Zazgornik.   

Abstract

Progression of diabetic nephropathy from the stage of macroproteinuria with near-normal renal function until start of dialysis was compared in 16 patients with type I and 16 patients with type II diabetes mellitus. The mean creatinine clearance at the beginning of the study was 89 +/- 13 ml/min/1.73 m2 in patients with type I and 81 +/- 6 ml/min/1.73 m2 in those with type II diabetes. Dialysis was started after a mean interval of 77 (44-133) months, when creatinine clearance had decreased to 8 +/- 2 ml/min/1.73 m2 in type I diabetic patients. The respective figures for type II diabetic patients were 81 (40-124) months and 7 +/- 2 ml/min/1.73 m2. The mean rate of decrease in creatinine clearance was 1.05 +/- 0.45 ml/min/month in type I and 0.91 +/- 0.41 ml/min/month in type II diabetes. The mean rate of decrease was 1.46 +/- 0.30 ml/min/month in type I diabetic patients with a systolic BP > 160 mmHg versus 0.80 +/- 0.42 ml/min/month with < 160 mmHg (P < 0.01). In the type II diabetics the respective figures were 1.38 +/- 0.40 ml/min/month versus 0.78 +/- 0.15 ml/min/month (P < 0.01). During the observation period the prevalence of coronary heart disease increased from 6 to 50% in type I and from 31 to 87% in type II diabetes. In conclusion, the rate of progression of diabetic nephropathy during the predialytic phase is similar in type I and type II diabetes; BP adversely affects the rate of progression to the same extent in both groups.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7800207     DOI: 10.1093/ndt/9.8.1097

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  14 in total

Review 1.  [Nephropathy and hypertension in type II diabetes].

Authors:  E Ritz; K Bergis; K Strojek; C Keller
Journal:  Med Klin (Munich)       Date:  1997-07-15

Review 2.  Identifying and slowing progressive chronic renal failure.

Authors:  B Curtis; B J Barrett; A Levin
Journal:  Can Fam Physician       Date:  2001-12       Impact factor: 3.275

Review 3.  Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress.

Authors:  Bruce A Perkins; Andrzej S Krolewski
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

Review 4.  [Protection of renal function in diabetics].

Authors:  C Hasslacher
Journal:  Internist (Berl)       Date:  2007-07       Impact factor: 0.743

Review 5.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

6.  In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

Authors:  Bruce A Perkins; Linda H Ficociello; Bijan Roshan; James H Warram; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2010-01       Impact factor: 10.612

7.  Smoking in diabetic nephropathy: sparks in the fuel tank?

Authors:  Vishal Arvind Chakkarwar
Journal:  World J Diabetes       Date:  2012-12-15

8.  Association between smoking and chronic kidney disease: a case control study.

Authors:  Rabi Yacoub; Habib Habib; Ayham Lahdo; Radwan Al Ali; Leon Varjabedian; George Atalla; Nader Kassis Akl; Saleem Aldakheel; Saeed Alahdab; Sami Albitar
Journal:  BMC Public Health       Date:  2010-11-25       Impact factor: 3.295

9.  Evolving pandemic diabetic nephropathy.

Authors:  Eli A Friedman
Journal:  Rambam Maimonides Med J       Date:  2010-07-02

10.  Cigarette smoking: an important renal risk factor - far beyond carcinogenesis.

Authors:  S R Orth
Journal:  Tob Induc Dis       Date:  2002-06-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.